Kara Palamountain
Kara Palamountain

Research Assistant Professor
Executive Director of the Global Health Initiative

Print Overview

Kara Palamountain is a Research Assistant Professor at the Kellogg School of Management and the Executive Director of the school's Global Health Initiative (GHI). The GHI is currently working in partnership with NU's Center for Innovation in Global Health Technologies (CIGHT) to develop and produce affordable HIV diagnostics for resource limited settings.

Ms. Palamountain has played a crucial role in identifying the more strategic aspects of introducing diagnostics developed by CIGHT. She has managed over 50 Kellogg field research teams conducting market entry analysis in over a dozen countries (Botswana, Brazil, Cambodia, China, India, Kenya, Lesothp, Mozambique, Namibia, South Africa, Tanzania, Uganda, Vietnam and Zambia).

Ms. Palamountain was a co-investigator on a cost-effectiveness project at Makerere University in Kampala, Uganda funded by the McLaughlin-Rotman Centre for Global Health. Ms. Palamountain has also served as an external reviewer for various projects under consideration by the Bill & Melinda Gates Foundation and a peer reviewer for Grand Challenges Canada. She also authored "Perspectives On Introduction And Implementation Of New Point-Of-Care Diagnostic Tests" and "Opportunities And Challenges For Cost-Efficient Implementation Of New Point-Of-Care Diagnostics For HIV And Tuberculosis" recently published in the Journal of Infectious Diseases and "Optimizing tuberculosis case detection through a novel diagnostic device placement model: The case of Uganda"

Ms. Palamountain is also the President of the Northwestern Global Health Foundation. Prior to her work at the Northwestern Global Health Foundation and at Kellogg, Kara worked as a management consultant in Deloitte's Healthcare practice for over six years (1998-2002; 2004-2006). She received her MBA from Kellogg in 2004 and her BBA from the University of Texas at Austin in 1998.

Print Vita
MBA, 2004, Kellogg School of Management, Northwestern University
BBA, 1998, Marketing and Business Honors Program, University of Texas at Austin

Academic Positions
Lecturer of International Business & Markets, Kellogg School of Management, Northwestern University, 2006-present
Executive Director of the Kellogg Global Health Initiative, Kellogg School of Management, Northwestern University, 2006-present
Research Assistant Professor, Kellogg School of Management, Northwestern University, 2006-present

Other Professional Experience
President, Northwestern Global Health Foundation, 2010-present
Senior Consultant, Deloitte Consulting, 2004-2006
Manager, Deloitte Consulting, 2004-2006
HIV/AIDS Initiatives Summer Intern, Abbott Laboratories, 2003-2003
Consultant, Deloitte Consulting, 1999-2002
Business Analyst, Deloitte Consulting, 1998-1999

Print Research
Palamountain, Kara, Wendy S. Stevens, David Kelso and Mark Fisher. 2015. An investigation of fingerstick blood collection for pointof-. South African Medical Journal. 105(3): 228-231.
Palamountain, Kara. 2015. Optimizing tuberculosis case detection through a novel diagnostic device placement model: The case of Uganda. PLoS ONE.(10(4): e0122574)
Pai, M. and Kara Palamountain. 2012. New tuberculosis technologies challenges for retooling and scale-up. International Journal of Tuberculosis and Lung Disease. 16(10): 1281-1290.
Palamountain, Kara, Jeff Baker, Elliot P. Cowan, Shaffiq Essajee, Laura T. Mazzola, Mutsumi Metzler, Marco L. Schito, Wendy S. Stevens, Gloria J. Young and Gonzalo J. Domingo. 2012. Perspectives on Introduction and Implementation of New Point-of-Care Diagnostic Tests. The Journal of Infectious Diseases.
Schito, Marco L., Trevor F. Peter, Sean Cavanaugh, Amy S. Piatek, Gloria J. Young, Heather Alexander, William Coggin, Gonzalo J. Domingo, Dennis Ellenberger, Eugen Ermantraut, Ilesh V. Jani, Achilles Katamba, Kara Palamountain, Shaffiq Essajee and David W. Dowdy. 2012. Opportunities and Challenges for Cost-Efficient Implementation of New Point-of-Care Diagnostics for HIV and Tuberculosis.. The Journal of Infectious Diseases. jis044v2-jis044
Palamountain, Kara and A. Nabatiyan. 2011. Towards the development of point-of-care diagnostics for global health needs. Clinical Laboratory International.
Diermeier, Daniel, Kara Palamountain, Annette Krauss, Kearsley A. Stewart and David Kelso. 2010. University leadership for innovation in global health and HIV/AIDS diagnostics. Global Public Health. 5(2): 189-196.
Working Papers
Palamountain, Kara, Kearsley A. Stewart, Daniel Diermeier, Annette Krauss and David Kelso. 2009. Triangulation: A new model for innovation in Global Health and HIV/AIDS Diagnostics.
Palamountain, Kara, Sachin Waikar, Andrea Hanson and Katherine Nelson. 2008. Balancing Access with Accuracy for Infant HIV Diagnostics in Tanzania (A). Case 5-308-502(A) (KEL383).
Calkins, TimothyKara Palamountain, Aniruddha Chatterjee, Robert Frantz, Elizabeth Hart, Sean Mathewson and Gabriela Perez-Hobrecker. 2015. Fighting Childhood Pneumonia in Uganda. Case 5-413-755 (KEL874).
Palamountain, Kara, Sachin Waikar, Andrea Hanson and Katherine Nelson. 2008. Balancing Access with Accuracy for Infant HIV Diagnostics in Tanzania (B). Case 5-308-502(B) (KEL384).

Print Teaching
Full-Time / Part-Time MBA
Global Initiatives in Management (GIM) (INTL-473-0)
All FT GIM classes will hold a final, mandatory class session on Wednesday, April 6th from 9:00 AM - 12:00 PM

Global Initiatives in Management (GIM) is an international experiential learning course designed to provide students with an introduction to the unique business opportunities, management practices and market dynamics of a specific region or global industry. The course combines in-class lectures, reading discussions and case studies during the winter quarter with ten days of international field research over spring break. Immersed in the culture and language of their host countries, students will have the opportunity to meet with local business and government leaders, conduct interviews and collect data for their group research projects, and experience some of the unique social and cultural facets of the region. Final presentations and written research reports are due in spring quarter after completion of the overseas portion of the class. Each class section is taught by a faculty member with deep knowledge of the region or industry and supported by an advisor from the Kellogg staff who assists students in planning the field experience. Students are financially responsible for their travel costs, and financial aid is available to those who qualify.

Medical Technologies in Developing Countries (KPPI-973-5)

**This course was formerly listed as KPPI-973-A/KPPI-973-B**

The full course takes place over two quarters; KPPI-973-5 in both Winter & Spring, as well as two weeks of in-country field work

The Medical Technologies in Developing Countries course provides students the unique opportunity to inform the design and launch of medical technologies for developing countries by conducting in-country market research. The students' findings will be shared with the developers of the medical technologies, including Northwestern University and several companies and philanthropists.

Prior market research trips have taken place in India, Kenya, Mozambique, Tanzania, Uganda, Malawi and Zambia, each with a focus on medical technologies such as HIV tests, tuberculosis tests, and mobile health technologies for pediatric health.

Students will spend five weeks in the classroom (KPPI-973-5) learning the science of HIV/AIDS, tuberculosis, and other high-burden diseases; the background on medical technologies under development for these markets; the essentials for conducting medical product market research in these geographies; the basic economics, culture, and politics of the country of interest; and the fundamentals of the country's healthcare system. Following this initial coursework, students will spend two weeks on the ground understanding how the medical technologies are perceived by the key stakeholders in the market, including: end-users at hospitals and clinics, government officials, and NGOs and distributors. After the field work, students will then return for five weeks in the classroom (KPPI-973-5) where they will learn to analyze their field work, synthesize key findings and provide recommendations to the developers of these medical technologies.

**Admittance to this course is by application only.**
Your application for this class will also ensure that you will be enrolled in KPPI-973-5 in spring. Students may not drop after the first week of the class.